Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Vabysmo


Contraindicated
Teratogenic and embryotoxic

Contraindicated
Vabysmo :
Type Medicine Authorised
Originator B
Agent Omnipharma
Distributor Omnipharma
Laboratory Roche
Responsible Party F. Hoffmann La Roche Ltd, Basel
Origin Switzerland
Manufacturer F. Hoffmann La Roche Kaiseraugst
Origin Switzerland
ATC S01LA09

Your comment will appear shortly after approval

Vabysmo :

Revision Date : 21/03/2024


Effect Frequency
Cataract Very Common
Cataract traumatic Rare
Conjunctival haemorrhage Common
Conjunctival hyperaemia (Conjunctival redness) (Conjunctival injection) Uncommon
Corneal abrasion Common
Endophthalmitis Uncommon
Eye irritation Common
Eye pain Common
Eye pruritus Uncommon
Foreign body sensation in eyes Uncommon
Intraocular pressure increased Common
Iridocyclitis Uncommon
Iritis Uncommon
Lacrimation increased (Epiphora) Common
Ocular discomfort Uncommon
Ocular hyperaemia Uncommon
Procedural pain Uncommon
Retinal detachment Uncommon
Retinal pigment epithelial tear Common
Retinal tear Uncommon
Retinal vasculitis Not known
Uveitis Uncommon
Vision blurred Uncommon
Visual acuity reduced Uncommon
Vitreous detachment Common
Vitreous floaters Common
Vitreous haemorrhage Uncommon

Different Units By MoH Code

Revision Date : 21/03/2024

Revision Date : 21/03/2024

Vabysmo  MoH 11708 :
Form Solution for injection
Packaging Bottle
Package Size Box of 1
Strength 6mg/0.05ml
Storage Condition 2-8°C Do not freeze
Public Price 54991170,32 L.L.
Stratum E1
NSSF ✘
Quarantine ✘
Reg. Number 13123/1
Submission date 2023
Registration Year 16/07/2024


Price Comparison

● Country: Lebanon
● Form: Solution for injection
● Package Size: Box of 1
● Public Price: 54991170.32 LBP ( 54,991,170.32 LBP )
● Pack size unit used: 1
● Cost/Unit: 54991170,32 LBP ( 54,991,170.00 LBP )
● Pricing Date: 10/11/2025

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Neovascular (wet) Age-related macular degeneration (AMD) : (Adults)
● Cost/Unit: 54991170,32 LBP ( 54,991,170.00 LBP )
● Cost/Day: 219964681,28 LBP ( 219,964,681.00 LBP )
● Cost/Month: 6598940438,4 LBP ( 6,598,940,438.00 LBP )
Visual impairment due to diabetic macular oedema (DME) : (Adults)
● Cost/Unit: 54991170,32 LBP ( 54,991,170.00 LBP )
● Cost/Day: 219964681,28 LBP ( 219,964,681.00 LBP )
● Cost/Month: 6598940438,4 LBP ( 6,598,940,438.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info